Monoclonal antibody MAb-170 for immunoscintigraphic detection of ovarian tumors.
暂无分享,去创建一个
[1] P. Schneider,et al. Gamma probe location of 111 indium‐labeled B72.3: An extension of immunoscintigraphy , 1992, Journal of surgical oncology.
[2] W. Schmidt,et al. [A clinical evaluation of MAb BW 835/6 in breast and ovarian cancer]. , 1992, Nuklearmedizin. Nuclear medicine.
[3] P. Kenemans,et al. Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer. , 1992, Nuclear medicine communications.
[4] S. McQuarrie,et al. MAb 170H.82: an evaluation of a novel panadenocarcinoma monoclonal antibody labelled with 99Tcm and with 111In. , 1992, Nuclear medicine communications.
[5] S. Canevari,et al. Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody. , 1991, European journal of cancer.
[6] R. Golding,et al. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma]. , 1991, Nederlands tijdschrift voor geneeskunde.
[7] B. Longenecker,et al. Two novel monoclonal antibodies have potential for gynecologic cancer imaging , 1991 .
[8] M. Salvatore,et al. Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[9] P. Kenemans,et al. Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] B. Shepstone,et al. Immunoscintigraphy of endometriosis , 1990, British journal of obstetrics and gynaecology.
[11] S. Mather,et al. Radiolabelled Stripped Mucin, SM3, Monoclonal Antibody for Immunoscintigraphy of Ovarian Tumours , 1990, The International journal of biological markers.
[12] M. Seppälä,et al. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125. , 1990, Cancer research.
[13] R. Wahl. Radiolabeled monoclonal antibodies for the diagnosis and treatment of ovarian carcinoma. , 1990, Frontiers of radiation therapy and oncology.
[14] A. D. Van den Abbeele,et al. Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125. , 1989, American journal of obstetrics and gynecology.
[15] S. Ménard,et al. Immunohistochemical Reactivity of a Monoclonal Antibody Prepared against Human Ovarian Carcinoma on Normal and Pathological Female Genital Tissues , 1989, Tumori.
[16] L. Mansi,et al. Diagnosis of ovarian cancer with radiolabelled monoclonal antibodies: our experience using 131I-B72.3. , 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[17] N. Pateisky,et al. [Immunoscintigraphy and intraoperative tumor search in ovarian cancer]. , 1989, Archives of gynecology and obstetrics.
[18] P. Kenemans,et al. Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens. , 1988, European journal of obstetrics, gynecology, and reproductive biology.
[19] G. Hör,et al. Radioimmunoscintigraphy Using Monoclonal Antibodies to CEA, CA 19-9 and CA 125 , 1988, The International journal of biological markers.
[20] P. Fumoleau,et al. Immunoscintigraphy of recurrences of gynecologic carcinomas. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] M. Slevin,et al. A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] K. Czerwenka,et al. Radioimmunodetection in patients with suspected ovarian cancer. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] W. Bodmer,et al. 123I radioiodinated antibody imaging of occult ovarian cancer , 1985, Cancer.